文献速递认知障碍与谵妄多重用药

老年痴呆患者长期抗精神病药停用成功性的系统评价

Discontinuation of Long-Term Antipsychotic Drug Use for Behavioral and Psychological Symptoms in Older Adults Aged 65 Years and Older With Dementia.
PubMed 文献 · J Am Med Dir Assoc · 2018-08-09

该Cochrane系统评价与荟萃分析纳入10项随机对照试验共632名65岁及以上痴呆患者,评估停用长期抗精神病药物对行为心理症状(BPSD)的成功性。低质量证据表明,停用对研究完成率及总体BPSD可能几乎无影响,但在部分对药物有应答的精神病或激越患者中停药与症状复发退出风险升高相关。

要点

  • 多数65岁及以上痴呆患者长期抗精神病药用于BPSD可成功停用,但证据质量低。
  • 对曾因精神病、激越或攻击行为且对药物有应答者,停药可能增加症状复发退出风险。
  • 基线BPSD较严重者停药后BPSD可能加重,需个体化评估。

核心结论

  • 低质量证据表明,在大多数65岁及以上痴呆成人中,长期用于BPSD的抗精神病药物可能可以成功停用。

研究设计与样本

  • Cochrane系统评价与荟萃分析,检索8个数据库(2018年1月),纳入10项随机对照试验共632名65岁及以上老年人。

主要发现

  • 基于7项研究(n=446)评估,停用抗精神病药对研究完成率可能几乎无影响(低质量证据)。
  • 在2项纳入对药物治疗有应答的精神病、激越或攻击行为患者的试验中,停药与因症状复发提前退出研究风险较高或至症状复发时间较短相关。
  • 7项试验(n=519)低质量证据显示,停用对用不同量表测量的总体BPSD可能几乎无影响。
  • 2项试验的亚组分析提示,基线BPSD较严重者停药可能与BPSD加重相关。

关键数值与推荐

  • 成功结局定义为持续停用抗精神病药物至研究期结束。

临床怎么用

  • 对多数65岁及以上痴呆患者的长期抗精神病药用于BPSD可考虑尝试停用,但需权衡个体复发风险。
  • 对曾因精神病、激越或攻击行为且对药物有应答者,或基线BPSD较重者,停药需更谨慎监测。

局限性

  • 证据质量低,主要结局评估受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antipsychotic drugs are often used to treat behavioral and psychological symptoms (BPSD) in adults aged 65 years and older with dementia, although there is uncertainty about the effectiveness of long-term use for this indication and there are concerns that they may cause harm. OBJECTIVES: To evaluate whether discontinuation of long-term antipsychotic drugs for BPSD is successful in adults aged 65 years and older with dementia. This article is based on a Cochrane review updated in 2018. DESIGN: A Cochrane systematic review and meta-analysis. SETTING AND PARTICIPANTS: Eight databases were searched in January 2018 to identify 10 randomized controlled trials with 632 older adults. MEASURES: We used standard methodological procedures according to the Cochrane Handbook for Systematic Reviews of Interventions. We assessed the number of patients completing the study. We considered sustained withdrawal of antipsychotics until the end of the study period as successful outcome. RESULTS: Based on assessment of 7 studies (n = 446), discontinuation may make little or no difference to whether or not participants complete the study (low-quality evidence). In 2 trials, including participants with psychosis, agitation, or aggression who had responded to antipsychotic treatment, discontinuation of antipsychotics was associated with a higher risk of leaving the study prematurely because of symptomatic relapse or a shorter time to symptomatic relapse. We found low-quality evidence from 7 trials (n = 519) that discontinuation may make little or no difference to overall BPSD, measured using various scales. There was some evidence from subgroup analyses in 2 trials that discontinuation may be associated with a worsening of BPSD in participants with more severe BPSD at baseline. CONCLUSIONS: Our meta-analysis revealed that there is low-quality evidence that long-term antipsychotic drugs for BPSD may be successfully discontinued in most adults aged 65 and older.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Van Leeuwen E, Petrovic M, van Driel ML, et al. Discontinuation of Long-Term Antipsychotic Drug Use for Behavioral and Psychological Symptoms in Older Adults Aged 65 Years and Older With Dementia. J Am Med Dir Assoc. 2018. PMID: 30100234. doi:10.1016/j.jamda.2018.06.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。